N. Lee

发表

Chemical modification of capillary column for electrophoretic separations of transition metal ions

Chuen‐Ying Liu, Gi J. Chen, N. Lee, 1995 .

Apparent protein kinase activity in oligodendroglial chromatin after chronic morphine treatment.

H. Loh, N. Lee, K. Oguri, 1976, Biochemical pharmacology.

Regulation by lysine of production of threonine-sensitive aspartokinase.

W. Shive, N. Lee, E. M. Lansford, 1966, Biochemical and biophysical research communications.

A study of the mechanism of lysine-sensitive aspartokinase control by lysine

W. Shive, N. Lee, E. M. Lansford, 1966 .

Treatment of stroke with opiate antagonists — Effects of exogenous antagonists and dynorphin 1–13

Y. Hosobuchi, N. Lee, D. Baskin, 1985, Neuropeptides.

[Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays.

N. Lee, P. Sánchez-Blázquez, J. Garzón, 1984, European journal of pharmacology.

Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact.

P. Seeburg, P. Schofield, P. Seeburg, 1989, The EMBO journal.

Opioid receptor polymorphisms and opioid abuse.

N. Lee, A. Smith, A. P. Smith, 2002, Pharmacogenomics.

Role of zinc in ALS

N. Lee, A. Smith, A. P. Smith, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Conformation of β-endorphin analogues in cerebroside sulfate solution

N. Ling, H. Loh, J. Chang, 1981 .

Specific reduction of delta-opioid receptor binding in transfected NG108-15 cells.

D. Ann, H. Loh, N. Lee, 1992, Journal of Biological Chemistry.

Possible regulatory function of dynorphin and its clinical implications

N. Lee, A. Smith, A. P. Smith, 1984 .

Dynorphin1–13: interaction with other opiate ligand bindings in vitro

J. Gerhart, H. Loh, N. Lee, 1984, Brain Research.

Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.

N. Lee, P. Sánchez-Blázquez, J. Garzón, 1982, Life sciences.

ß-endorphin: stimulation of DNA-dependent RNA formation

Choh Hao Li, H. Loh, N. Lee, 1979 .

Antisense proenkephalin cDNA transfection decreases opioid binding in NG 108-15 cells.

H. Loh, I. Arany, N. Lee, 1992, Brain research. Molecular brain research.

Genetic mapping of opioid binding protein gene(s) to mouse Chromosome 9

C. Kozak, H. Loh, N. Lee, 2004, Mammalian Genome.

Isolation of a cDNA encoding a novel zinc-finger protein from neuroblastoma x glioma NG108-15 cells.

M. Wick, D. Ann, H. Loh, 1995, Gene.

[Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay.

N. Lee, L. He, L. Hooke, 1995, The Journal of pharmacology and experimental therapeutics.

Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.

H. Loh, A. Takemori, N. Lee, 1993, The Journal of pharmacology and experimental therapeutics.

Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.

H. Loh, A. Takemori, N. Lee, 1992, European journal of pharmacology.

Pharmacology of dynorphin.

N. Lee, A. Smith, A. P. Smith, 1988, Annual review of pharmacology and toxicology.

Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.

N. Lee, L. He, L. He, 1998, The Journal of pharmacology and experimental therapeutics.

Delta Opioid Receptor Enhancement of Mu Opioid Receptor-Induced Antinociception in Spinal Cord 1

N. Lee, He Li, 1998 .

Opioid-binding cell adhesion molecule (OBCAM)-related clones from a rat brain cDNA library.

H. Loh, N. Lee, D. Lippman, 1992, Gene.

An opioid binding protein is specifically down-regulated by chronic morphine treatment in dorsal root and trigeminal ganglia

N. Lee, R. Elde, A. Kalyuzhny, 1995, Neuroscience.

In vivo incorporation of a cholesterol-like fluorescent probe into rat brain membranes.

R. L. Morgan, H. Loh, N. Lee, 1983, Journal of pharmacological methods.

Chelation Properties of Highly Selective and Affinity Polymeric Complexing Agents

Chuen‐Ying Liu, N. Lee, 1995 .

Morphine Tolerance in Spinal Cord Is Due to Interaction between μ- and δ-Receptors

N. Lee, A. Smith, Y. Ben, 2002 .

A monoclonal antibody that inhibits opioid binding to rat brain membranes.

H. Loh, N. Lee, S. Roy, 1988, Biochemical and biophysical research communications.

Possible nuclear protein kinase regulation of homologous ribonucleic acid polymerases from small dense nuclei of mouse brain during morphine tolerance-dependence. Involvement of cyclic 3',5'-adenosine monophosphate.

H. Loh, N. Lee, K. Stokes, 1981, Biochemical pharmacology.

Malate dehydrogenase of ox kidney. Comparison of the reactivity of sulfhydryl groups and their relationship to activities of the mitochondrial and cytoplasmic enzymes.

E. Kun, N. Lee, D. Skilleter, 1970, European journal of biochemistry.

Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.

N. Lee, J. Fedynyshyn, G. Kwiat, 1989, European journal of pharmacology.

μ type opioid receptors in rat periaqueductal gray‐enriched P2 membrane are coupled to G‐protein‐mediated inhibition of adenylyl cyclase

N. Lee, J. Fedynyshyn, J.P. Fedynyshyn, 1989, FEBS letters.

Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins

N. Lee, J. Fedynyshyn, 1989, Brain Research.

Effect of chronic morphine treatment on brain chromatin template activities in mice.

H. Loh, N. Lee, I. Ho, 1975, Biochemical pharmacology.

Dynorphin(1–13) improves survival in cats with focal cerebral ischaemia

Y. Hosobuchi, H. Loh, N. Lee, 1984, Nature.

The multiple site β-endorphin receptor

H. Loh, N. Lee, A. Smith, 1983 .

Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.

H. Loh, N. Lee, J. K. Chang, 1981, The Journal of pharmacology and experimental therapeutics.

Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow.

H. Loh, N. Lee, S. Ramakrishnan, 1991, European journal of pharmacology.

Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.

H. Loh, N. Lee, S. Thayer, 1992, Molecular pharmacology.

SYNTHESIS AND COORDINATION BEHAVIOUR OF HYDROXAMATE RESIN WITH VARYING SPACER GROUPS

N. Lee, M. J. Chen, C. Y. Liu, 1992 .

Determination of vanadium, molybdenum and tungsten in complex matrix samples by chelation ion chromatography and on-line detection with inductively coupled plasma mass spectrometry

Chuen‐Ying Liu, N. Lee, Shu-Yu Lin, 2002 .

γ-Aminobutyrohydroxamate resins as stationary phases of chelation ion chromatography

Chuen‐Ying Liu, N. Lee, Jian-Lian Chen, 1998 .

Chelation ion chromatography as a technique for trace elemental analysis in complex matrix samples

Chuen‐Ying Liu, N. Lee, Tsyr-Hung Wang, 1997 .

Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.

H. Loh, J. Huidobro-Toro, N. Lee, 1984, The Journal of pharmacology and experimental therapeutics.

Interaction of dynorphin with neurotensin on the guinea pig ileum myenteric plexus.

H. Loh, J. Huidobro-Toro, N. Lee, 1982, Life sciences.

Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.

J. Huidobro-Toro, N. Lee, E. Way, 1982, The Journal of pharmacology and experimental therapeutics.

Role of Heteromeric GPCR Interactions in Pain/Analgesia

N. Lee, A. Smith, A. P. Smith, 2005 .

Opiate and peptide interaction: effect of enkephalins on morphine analgesia.

H. Loh, N. Lee, J. K. Chang, 1980, European journal of pharmacology.

Enzymatic Reconstitution of Brain Membrane and Membrane Opiate Receptors

D. Deamer, H. Loh, N. Lee, 1986, Journal of neurochemistry.

Mu-opioid receptor is associated with phosphatase activity.

H. Loh, N. Lee, S. Roy, 1986, Biochemical and biophysical research communications.

Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates F.G. Fang, H.L. Fields and N.M. Lee, J. Pharmacol. Exp. Ther., 238 (1986) 1039–1044

H. Fields, N. Lee, F. G. Fang, 1986, Pain.

Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.

H. Loh, N. Lee, H. J. Friedman, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Opioid receptor interactions: local and nonlocal, symmetric and asymmetric, physical and functional.

N. Lee, A. P. Smith, 2003, Life sciences.

Alteration of OBCAM conformation as a result of opioid receptor expression and opioid ligand treatment

Lei Yu, T. Reisine, N. Lee, 1995, Brain Research.

Opioid-induced inhibition of voltage-gated calcium channels parallels expression of ω-conotoxin-sensitive channel subtype during differentiation of NG108-15 cells

H. Loh, N. Lee, S. Thayer, 1993, Brain Research.

Computer analysis of the effect of beta-endorphin and dynorphin and related compounds on opioid binding to mouse brain membrane.

H D Landahl, J Garzon, N M Lee, 1989, Computers in biology and medicine.

Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse.

H. Loh, N. Lee, J. K. Chang, 1981, European journal of pharmacology.

Lipid Requirement for μ Opioid Receptor Binding

H. Loh, N. Lee, J. Hasegawa, 1987 .

A study of deoxyribonucleic acid binding of narcotic analgesics.

H. Loh, N. Lee, 1975, Biochemical pharmacology.

Alterations of macromolecule biosynthesis after chronic administration of opiates and ethanol.

R. Harris, H. Loh, N. Lee, 1977, Advances in experimental medicine and biology.

Regulation of mitochondrial metabolism by specific cellular substances. II. The nature of stimulation of mitochondrial glutamate metabolism by a cytoplasmic component.

E. Kun, N. Lee, E. Kearney, 1969, Biochemistry.

Adaptation of brain lipid bilayers to ethanol-induced fluidization. Species and strain generality.

R. Cooke, D. Johnson, N. Lee, 1980, Biochemical pharmacology.

[3H]Morphine binding is enhanced by IL‐1‐stimulated thymocyte proliferation

H. Loh, N. Lee, S. Ramakrishnan, 1991, FEBS letters.

Effects of opioids on proliferation of mature and immature immune cells.

H. Loh, N. Lee, A. Smith, 1993, Advances in experimental medicine and biology.

beta-Endorphin: formation of alpha-helix in lipid solutions.

H. Loh, N. Lee, J. T. Yang, 1979, Proceedings of the National Academy of Sciences of the United States of America.

The dependence of oxidative phosphorylation and ATP-ase of liver mitochondria on bound Mg2+.

E. Kun, N. Lee, D. Skilleter, 1970, Biochemical and Biophysical Research Communications - BBRC.

Consequence of dynorphin-A administration on anterior pituitary hormone concentrations in the adult male rhesus monkey.

Y. Hosobuchi, N. Lee, P. Gilbeau, 1987, Neuroendocrinology.

PHOSPHORYLATION AND METHYLATION OF CHROMATIN PROTEINS FROM MOUSE BRAIN NUCLEI

N. Lee, H. Loh, 1977, Journal of neurochemistry.

Prevention of Ca2+ induced cation efflux from liver mitochondria by a cytoplasmic factor and by oligomycin

E. Kun, N. Lee, I. Wiedemann, 1971, FEBS letters.

Control of cation movements in liver mitochondria by a cytoplasmic factor.

E. Kun, N. Lee, I. Wiedemann, 1971, Biochemical and biophysical research communications.

Interaction of a cytoplasmic factor with electron and ion transfer coupled functions of mitochondria.

E. Kun, N. Lee, E. Kearney, 1970, Biochemical and biophysical research communications.

Dynorphin interaction at the κ-opiate site

H. Loh, J. Huidobro-Toro, N. Lee, 1981 .

A protein-lipid model of the opiate receptor.

N. Lee, A. Smith, A. P. Smith, 1980, Life sciences.

Opioid-like properties of seven dynorphin (1–10) analogs

N. Lee, J. K. Chang, J. Muller, 1984, Neuropeptides.

Dynorphin B-29: Chemical synthesis and pharmacological properties in opioid systems in vitro

N. Lee, J. K. Chang, P. Sánchez-Blázquez, 1984, Neuropeptides.

Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.

J. Gerhart, H. Loh, N. Lee, 1984, Biochemical pharmacology.

Effect of dynorphin-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression.

H. Loh, N. Lee, F. Tulunay, 1983, European journal of pharmacology.

Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys.

M. Aceto, N. Lee, W. Dewey, 1982, European journal of pharmacology.

Dynorphin: Interaction with putative kappa-sites on the guinea pig ileum

J. Huidobro-Toro, N. Lee, K. Yoshimura, 1982 .

Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens

N. Lee, V. Höllt, P. Sánchez-Blázquez, 1984, Neuropeptides.

Horace H. Loh, Nancy M. Lee and Andrew P. Smith reply

H. Loh, N. Lee, A. P. Smith, 1983 .

Opioid-binding protein (OBCAM) is rich in β-sheets

H. Loh, N. Lee, Jen-Tsi Yang, 1990 .

Transfection of NG108-15 cells with antisense opioid-binding cell adhesion molecule cDNA alters opioid receptor-G-protein interaction.

H. Loh, N. Lee, P. Govitrapong, 1993, The Journal of biological chemistry.

Different molecular weight forms of opioid receptors revealed by polyclonal antibodies.

H. Loh, N. Lee, S. Roy, 1988, Biochemical and biophysical research communications.

Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.

H. Loh, N. Lee, M. Jen, 1983, European journal of pharmacology.

DYNORPHIN: DIFFERENTIAL INTERACTIONS WITH OPIATES AND PEPTIDES IN NAIVE AND MORPHINE TOLERANT MICE

N. Lee, F. Tulunay, M. Jen, 1981 .

A study of lysyl-ribonucleic acid synthetase in relation to substrate conformation.

W. Shive, N. Lee, E. M. Lansford, 1967, Archives of biochemistry and biophysics.

Mouse Brain DNA‐Dependent RNA Polymerases After Chronic Morphine Treatment

H. Loh, N. Lee, K. Stokes, 1980, Journal of neurochemistry.

Effect of acute and chronic ethanol treatment on rat brain phospholipid turnover.

H. Loh, N. Lee, H. J. Friedman, 1980, Biochemical pharmacology.

Endogenous opioid peptides: comparative evaluation of their receptor affinities in the mouse brain.

H. Loh, N. Lee, V. Höllt, 1983, Life sciences.

Ethanol-induced fluidization of brain lipid bilayers: required presence of cholesterol in membranes for the expression of tolerance.

R. Cooke, H. Loh, D. Johnson, 1979, Molecular pharmacology.

Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration.

P. Green, N. Lee, 1988, European journal of pharmacology.

Dynorphin A modulates acute and chronic opioid effects.

N. Lee, L. Hooke, L. He, 1995, The Journal of pharmacology and experimental therapeutics.

Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment

P. Schiller, N. Lee, Y. Ben, 2004, British journal of pharmacology.

Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.

H. Loh, N. Lee, F. Tulunay, 1981, European journal of pharmacology.

[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.

P. Schiller, N. Lee, T. M. Nguyen, 2002, Current medicinal chemistry.

Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.

N. Lee, Y. Ben, P. Riba, 2002, The Journal of pharmacology and experimental therapeutics.

Effects of high intravenous doses of dynorphin A(1–13) on tail flick latency and central nervous system histology in rats

D. Hatsukami, N. Lee, W. Anderson, 1995, Pharmacology Biochemistry and Behavior.

[3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.

N. Lee, P. Sánchez-Blázquez, J. Garzón, 1984, The Journal of pharmacology and experimental therapeutics.

Adaptation to ethanol-induced fluidization of brain lipid bilayers.

R. Cooke, D. Johnson, N. Lee, 1979, Drug and alcohol dependence.

Characterization of opioid-binding proteins and other molecules related to opioid function

H. Loh, N. Lee, A. Smith, 1993 .

Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells.

H. Loh, N. Lee, S. Roy, 1991, European journal of pharmacology.

Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.

H. Loh, N. Lee, S. Roy, 1992, The Journal of pharmacology and experimental therapeutics.

Modification of opioid agonist binding by pertussis toxin

H. Loh, N. Lee, M. Abood, 1986, Brain Research.

Medications Development for the Treatment of Pregnant Addicts and Their Infants

B. Zuckerman, K. Befort, C. Gaveriaux-Ruff, 1995 .

Adaptation to ethanol-induced fluidization of brain lipid bilayers; cross-tolerance and reversibility.

R. Cooke, H. Loh, D. Johnson, 1980, Molecular pharmacology.

Effects of dynorphin 1–13 on opiate binding and dopamine and GABA uptake in stroked cat brain

Y. Hosobuchi, H. Loh, N. Lee, 1986, Brain Research.

Lipid requirement for mu opioid receptor binding.

H. Loh, N. Lee, J. Hasegawa, 1987, Journal of neurochemistry.

Morphine tolerance in mice is independent of polymorphisms in opioid receptor sequences

N. Lee, P. Riba, T. Gant, 2001, Brain Research Bulletin.

DynorphinA-(2-17) restores spinal/supraspinal morphine synergy in morphine-tolerant mice.

N. Lee, Li He, 1997, The Journal of pharmacology and experimental therapeutics.

DynorphinA-(2–17) Restores Spinal/Supraspinal Morphine Synergy in Morphine-Tolerant Mice 1

N. Lee, He Li, 1997 .

Dynorphin: specific binding to opiate receptors.

H. Landahl, N. Lee, 1986, NIDA research monograph.